‘How to’ – Stability Studies

How to Implement Stability Testing for Drug Products in Compliance with Regional Regulatory Requirements

How to Implement Stability Testing for Drug Products in Compliance with Regional Regulatory Requirements Stability Testing for Drug Products: Navigating Regional Regulatory Requirements Introduction Drug products must meet specific stability requirements to ensure safety, efficacy, and quality across different regions. Various regulatory authorities, such as the US FDA, EMA, and other regional agencies, have distinct…

'How to' - Stability Studies

How to Conduct Stability Studies for Novel Excipient-Drug Combinations in Compliance with Regulatory Guidelines

How to Conduct Stability Studies for Novel Excipient-Drug Combinations in Compliance with Regulatory Guidelines Stability Testing for Novel Excipient-Drug Combinations: A Regulatory Guide Introduction Novel excipients are substances not previously used in approved drug products, often introduced to enhance formulation properties or delivery of the active drug. Stability testing for drug products containing novel excipient-drug…

'How to' - Stability Studies

How to Address Stability Testing for Drug Products with Multiple Active Ingredients under Regulatory Guidelines

How to Address Stability Testing for Drug Products with Multiple Active Ingredients under Regulatory Guidelines Stability Testing for Drug Products with Multiple Active Ingredients: A Regulatory Guide Introduction Drug products with multiple active ingredients, such as combination therapies, require thorough stability testing to ensure that each ingredient remains stable and maintains its intended efficacy and…

'How to' - Stability Studies

How to Implement ICH Q1A(R2) for Stability Testing in Tropical and Subtropical Regions

How to Implement ICH Q1A(R2) for Stability Testing in Tropical and Subtropical Regions Stability Testing in Tropical and Subtropical Regions: Applying ICH Q1A(R2) Guidelines Introduction Drug products intended for distribution in tropical and subtropical regions face unique challenges due to high temperatures and humidity levels that can affect their stability. The ICH Q1A(R2) guideline provides…

'How to' - Stability Studies

How to Conduct Stability Studies for Drugs with Complex API in Compliance with Regulatory Guidelines

How to Conduct Stability Studies for Drugs with Complex API in Compliance with Regulatory Guidelines Stability Testing for Drugs with Complex APIs: A Regulatory Compliance Guide Introduction Drugs with complex Active Pharmaceutical Ingredients (APIs), such as peptides, proteins, and other large molecules, pose unique challenges in stability testing due to their susceptibility to degradation and…

'How to' - Stability Studies

How to Apply ICH Q10 for Pharmaceutical Quality System in Stability Studies

How to Apply ICH Q10 for Pharmaceutical Quality System in Stability Studies Applying ICH Q10 for Stability Studies: Enhancing Pharmaceutical Quality Systems Introduction ICH Q10, the Pharmaceutical Quality System guideline, provides a comprehensive framework for maintaining and improving the quality of pharmaceutical products throughout their lifecycle. Applying ICH Q10 principles to stability studies helps ensure…

'How to' - Stability Studies

How to Conduct Stability Testing for Modified-Release Formulations in Compliance with Regulatory Guidelines

How to Conduct Stability Testing for Modified-Release Formulations in Compliance with Regulatory Guidelines Stability Testing for Modified-Release Formulations: Ensuring Regulatory Compliance Introduction Modified-release formulations, such as extended-release, delayed-release, and controlled-release products, are designed to release their active ingredients over a specific period. Stability testing for these formulations is critical to ensure they maintain their intended…

'How to' - Stability Studies

How to Implement ICH Q8 for Stability Testing in Pharmaceutical Development

How to Implement ICH Q8 for Stability Testing in Pharmaceutical Development Applying ICH Q8 for Stability Testing in Pharmaceutical Development Introduction The ICH Q8 guideline, “Pharmaceutical Development,” emphasizes a systematic approach to development that ensures product quality through design, understanding, and control of manufacturing processes. Implementing ICH Q8 principles in stability testing helps to optimize…

'How to' - Stability Studies

How to Prepare Stability Data for Compliance with FDA’s Quality by Design (QbD) Approach

How to Prepare Stability Data for Compliance with FDA’s Quality by Design (QbD) Approach Stability Data Preparation for Compliance with FDA’s QbD Approach Introduction The FDA’s Quality by Design (QbD) approach emphasizes building quality into pharmaceutical products through a systematic understanding of processes and product characteristics. Preparing stability data under the QbD framework involves integrating…

'How to' - Stability Studies

How to Conduct Stability Studies for Dermatological Products in Compliance with Regulatory Guidelines

How to Conduct Stability Studies for Dermatological Products in Compliance with Regulatory Guidelines Stability Testing for Dermatological Products: A Regulatory Guide Introduction Dermatological products, including creams, ointments, gels, and lotions, require specific stability testing to ensure their safety, efficacy, and quality. These products are often sensitive to environmental factors such as light, temperature, and humidity,…

'How to' - Stability Studies